Pancreatic Cancer Research

ResearcherDong-A UniversityNo recent work listed

Yeon‐Jeong Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1482-7319; OpenAlex author ID A5101466741. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer Co-author DOI 10.3389/fphar.2022.890614↗
  2. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor. Co-author DOI 10.1038/s12276-021-00582-2↗
  3. DCPP1 is the mouse ortholog of human PAUF that possesses functional analogy in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2017.10.015↗
  4. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreati… Co-author DOI 10.18632/oncotarget.10123↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sang Seok Koh · 4 shared papers, 2016–2022 · strength 0.40
  2. Fen Jiang · 1 shared paper, 2022 · strength 0.16
  3. Seung‐Mo Hong · 1 shared paper, 2022 · strength 0.16
  4. Song Cheol Kim · 2 shared papers, 2016–2021 · strength 0.15
  5. Jinhoi Song · 2 shared papers, 2016–2017 · strength 0.13
  6. Wonbeak Yoo · 1 shared paper, 2021 · strength 0.11
  7. Seok‐Ho Kim · 1 shared paper, 2021 · strength 0.11
  8. Eunsung Jun · 1 shared paper, 2021 · strength 0.11
  9. Dana Jung · 1 shared paper, 2021 · strength 0.11
  10. Hayne Song · 1 shared paper, 2017 · strength 0.08
  11. Jae Min Lee · 1 shared paper, 2016 · strength 0.05
  12. Suhwan Chang · 1 shared paper, 2016 · strength 0.05
  13. Seok‐Ho Kim · 1 shared paper, 2016 · strength 0.05
  14. Tae Heung Kang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.